Any variant that winds up dominating in coming months will probably challenge a key line of treatment and protection for people with compromised immune systems—the drugs known as monoclonal antibodies.
The lawsuit was filed this month by a senior sales representative who worked for Eli Lilly for 11 years before resigning in June. The complaint seeks class-action status on behalf of thousand of employees and former employees of Lilly.
The Health and Hospital Corp. of Marion County is a defendant in a lawsuit that some worry would impact any Medicaid beneficiary receiving care in a government-owned facility.
Some critics see the released data as nothing more than a marketing ploy attempting to divert monopoly-busting tactics.
Advocates for the elderly, poor and people with disabilities say the legal challenge could severely threaten federal benefit programs, like Medicaid.
The FDA cleared the COVID-19 booster tweaks without requiring human test results—just like it approves yearly changes to flu vaccines.
Between 7 million and 23 million Americans—including 1 million who can no longer work—are suffering from the long-term effects of infection with the virus, according to government estimates.
A 10-year study by researchers from Poland, Norway and Sweden published in the New England Journal of Medicine questions the benefits of colonoscopy screening exams.
Catholic health care systems now control about 1 in 7 U.S. hospital beds, requiring religious doctrine to guide treatment, often to the surprise of patients.
Over the past year, nearly 40 states have ended emergency declarations that made it easier for doctors to use video visits to see patients in another state, according to the Alliance for Connected Care, which advocates for telemedicine use.
While the vast majority of people who are infected with COVID do not experience complications, the risk of preeclampsia and other severe issues has been documented to be much higher with infection.
Indianapolis-based Eli Lilly and Co. announced Thursday that it has received a Fast Track designation from the U.S. Food and Drug Administration to investigate its diabetes drug tirzepatide for the treatment of adults with obesity.
The Indiana Joint Replacement Institute is planning a $28 million, 35,000-square-foot facility at Innovation Mile, which is along 141st Street, between Olio and Prairie Baptist roads.
The Hamilton County campus will admit 20 nursing students for the spring semester and 20 more students for the fall semester. Enrollment increases are expected in future years.
In a ruling announced this week, Judge Andrew Carter of the U.S. District Court for the Southern District of New York said Elevance failed to show the lawsuit should be dismissed for lack of materiality.
That change in Federal Employees Health Benefits Program premiums is significantly larger than last year’s rise and marks the biggest increase in more than a decade, the government announced Friday.
Matt Sause, president and CEO of Roche Diagnostics North America since 2019, has been named CEO of Roche Diagnostics and a member of the corporate executive committee. He will relocate to the parent company’s offices in Basel, Switzerland.
The closure of the hospital will result in the layoffs of 77 employees, and more than 50 employees will be affected by the closures of the nine practices.
Some say doctors are raising the issue just to protect their turf and status.
The infrastructure of Indiana’s behavioral health treatment system is underfunded and in need of reform, a new report says.
